Oral antibiotics for the treatment of gram negative blood stream infections: a retrospective comparison of three classes.
Treatment of bacteremia with oral antibiotics has the potential to reduce hospital length of stay, treatment costs, and line related complications. To date, small trials have supported use of specific classes of antibiotics, primarily fluoroquinolones (FQ), in the treatment of gram-negative blood stream infections (GNBSI). At present, limited data exists evaluating treatment with beta-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX). The purpose of this study was to compare the treatment of GNBSI across three different oral antibiotic classes. A retrospective cohort of hospitalized patients with a GNBSI receiving initial intravenous antibiotic therapy followed by step-down oral therapy was conducted. Patients were divided into one of three oral antibiotic treatment groups: FQ, BL, or TMP-SMX. The composite primary endpoint was treatment failure, comprised of 30-day mortality, clinical relapse, or transition back to intravenous antibiotics. Additional endpoints included secondary infections and individual components within the primary endpoint. Categorical endpoints were analyzed using X2 or Fisher's exact while continuous variables were assessed with a one-way ANOVA. A total of 204 patients were included in the analysis. The majority of patients received FQ (n=136; 67%), followed by BL (n=46; 22%) and TMP-SMX (n=22;11%). Treatment failure occurred in 15 (7%) patients with no significance found between groups. Likewise, individual composite outcomes and secondary outcomes demonstrated no statistical significance. Transitioning to oral antibiotics to complete GNBSI treatment can offer many advantages. As FQ resistance increases, data supporting use of BL or TMP-SMX in treatment of GNBSI will become essential.